D-0278-2025 Class II

Recalled by Slate Run Pharmaceuticals — Columbus, OH

FDA drug recall D-0278-2025 was initiated by Slate Run Pharmaceuticals on Mar 7, 2025 and is designated Class II. Reason for recall: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits. Affected quantity: 56,790 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 26, 2025
Initiation Date
Mar 7, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
56,790 bottles

Product description

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Reason for recall

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Distribution pattern

Product was distributed to 8 distributors who may have further distribute the product nationwide.

Code information

Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0278-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0278-2025. Report a data issue: hello@regdatalab.com.